Ignite Creation Date:
2024-05-05 @ 4:43 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00301223
Status:
COMPLETED
Last Update Posted:
2021-01-22
First Post:
2006-03-07
Brief Title:
A Study to Assess the Efficacy Safety and Tolerability of Pregabalin in Patients With Symptoms of Neuropathic Pain
Sponsor:
Pfizers Upjohn has merged with Mylan to form Viatris Inc
Organization:
Pfizer
Study Overview
Official Title:
An 8-Week Multi-Center Randomized Double Blind Placebo-Controlled Study To Evaluate The Efficacy Safety And Tolerability Of Pregabalin 150mg-600mgDay Using A Flexible Dosing Schedule In The Treatment Of Subjects With Symptoms Of Neuropathic Pain
Status:
COMPLETED
Status Verified Date:
2011-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this study is to evaluate the efficacy safety and tolerability for pregabalin using a flexible optimized dose schedule compared to placebo in relieving the symptoms of neuropathic pain
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None